Organization
H. Lundbeck A/S
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
H. Lundbeck A/S
... 2018-2022 - Players Featured are Pfizer, AstraZeneca, Eli Lilly & Company, and Lundbeck - ResearchAndMarkets.com ...
... to commit to a larger phase 2 trial, despite its one-time partner Lundbeck walking away from the program. Tokyo-based Kyowa outlicensed the ex-Asia rights to ...
... study with the compound Lu AF82422. Lu AF82422, which was invented by Lundbeck in collaboration with Genmab, is the first antibody ever that Lundbeck brings ...
... being rated 2nd for eight of the 12 individual indicators of corporate reputation.Lundbeck was ranked 3rd out of 14 companies in 2017 by the 48 ...
... Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announce that the European Commission has approved Rxulti (brexpiprazole) ...
... drugs available in the market: - Pfizer - Eisai - Actavis - Lundbeck - Daiichi Sankyo - Novartis - TauRx - vTv Therapeutics - Profiles ...
... to hit the mark in Phase III clinical trials.Both Axovant's intepiridine and Lundbeck's idalopirdine failed their Phase III clinical trials, leaving the Alzheimer's pipeline no ...
... weapon in the fight against Alzheimer's disease might be your own body." Lundbeck, a global pharmaceutical company focused on psychiatric and neurological disorders, also subscribes ...
... PEGGY L. LUNDBECK (nee Lee) age 95, passed away on Tuesday, July 10, 2018. Beloved ...
Subscribe now for full coverage on H. Lundbeck A/S
Start My Free Trial